Tobias Huth

Tobias Huth

Auto-generated profile, based on publicly available information

Tobias Huth

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DDDiana Dominguez
Diana Dominguez
JTJos Tournoy
Jos Tournoy
DHDieter Hartmann
Dieter Hartmann
THTobias Huth
Tobias Huth
KCKim Cryns
Kim Cryns
BSBart De Strooper
Bart De Strooper
β-Secretase (BACE1) is the rate-limiting protease for the generation of the amyloid β-peptide (Aβ) in Alzheimer disease. Mice in which the bace1 gene is inactivated are reported to be healthy. However, the presence of a homologous gene encoding BACE2 raises the possibility of compensatory mechanisms. Therefore, we have generated bace1, bace2, and double knockout mice. We report here that BACE1 mice display a complex phenotype. A variable but significant number of BACE1 offspring died in the first weeks after birth. The surviving mice remained smaller than their littermate controls and presented a hyperactive behavior. Electrophysiologically, subtle alterations in the steady-state inactivation of voltage-gated sodium channels in BACE1-deficient neurons were observed. In contrast, bace2 knockout mice displayed an overall healthy phenotype. However, a combined deficiency of BACE2 and BACE1 enhanced the bace1–/– lethality phenotype. At the biochemical level, we have confirmed that BACE1 deficiency results in an almost complete block of Aβ generation in neurons, but not in glia. As glia are 10 times more abundant in brain compared with neurons, our data indicate that BACE2 could indeed contribute to Aβ generation in the brains of Alzheimer disease and, in particular, Down syndrome patients. In conclusion, our data challenge the general idea of BACE1 as a safe drug target and call for some caution when claiming that no major side effects should be expected from blocking BACE1 activity.

9 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RSRuth Sittl
Ruth Sittl
ALAngelika Lampert
Angelika Lampert
THTobias Huth
Tobias Huth
ESE. Theresa Schuy
E. Theresa Schuy
ALAndrea S. Link
Andrea S. Link
RCRichard Carr
Richard Carr
Infusion of the chemotherapeutic agent oxaliplatin leads to an acute and a chronic form of peripheral neuropathy. Acute oxaliplatin neuropathy is characterized by sensory paresthesias and muscle cramps that are notably exacerbated by cooling. Painful dysesthesias are rarely reported for acute oxaliplatin neuropathy, whereas a common symptom of chronic oxaliplatin neuropathy is pain. Here we examine the role of the sodium channel isoform Na V 1.6 in mediating the symptoms of acute oxaliplatin neuropathy. Compound and single-action potential recordings from human and mouse peripheral axons showed that cooling in the presence of oxaliplatin (30–100 μM; 90 min) induced bursts of action potentials in myelinated A, but not unmyelinated C-fibers. Whole-cell patch-clamp recordings from dissociated dorsal root ganglion (DRG) neurons revealed enhanced tetrodotoxin-sensitive resurgent and persistent current amplitudes in large, but not small, diameter DRG neurons when cooled (22 °C) in the presence of oxaliplatin. In DRG neurons and peripheral myelinated axons from Scn8a med/med mice, which lack functional Na V 1.6, no effect of oxaliplatin and cooling was observed. Oxaliplatin significantly slows the rate of fast inactivation at negative potentials in heterologously expressed mNa V 1.6r in ND7 cells, an effect consistent with prolonged Na V open times and increased resurgent and persistent current in native DRG neurons. This finding suggests that Na V 1.6 plays a central role in mediating acute cooling-exacerbated symptoms following oxaliplatin, and that enhanced resurgent and persistent sodium currents may provide a general mechanistic basis for cold-aggravated symptoms of neuropathy.

1 June 2012 in Neuron
Verified
Journal Article
Closed access
CTCarsten H. Tischbirek
Carsten H. Tischbirek
EWEva M. Wenzel
Eva M. Wenzel
FZFang Zheng
Fang Zheng
THTobias Huth
Tobias Huth
DADavide Amato
Davide Amato
TGTeja W. Groemer
Teja W. Groemer

22 March 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DMDorothee Möller
Dorothee Möller
ABAshutosh Banerjee
Ashutosh Banerjee
TUTaygun C. Uzuneser
Taygun C. Uzuneser
MSMarika Skultety
Marika Skultety
THTobias Huth
Tobias Huth
PGPeter Gmeiner
Peter Gmeiner

1 January 2012 in Molecular Pain
Verified
Journal Article
Open access
AKAlexandra B Klinger
Alexandra B Klinger
MEMirjam Eberhardt
Mirjam Eberhardt
ALAndrea S Link
Andrea S Link
BNBarbara Namer
Barbara Namer
LKLisa K Kutsche
Lisa K Kutsche
ALAngelika Lampert
Angelika Lampert
Background: Gain-of-function mutations of the nociceptive voltage-gated sodium channel Nav1.7 lead to inherited pain syndromes, such as paroxysmal extreme pain disorder (PEPD). One characteristic of these mutations is slowed fast-inactivation kinetics, which may give rise to resurgent sodium currents. It is long known that toxins from Anemonia sulcata, such as ATX-II, slow fast inactivation and skin contact for example during diving leads to various symptoms such as pain and itch. Here, we investigated if ATX-II induces resurgent currents in sensory neurons of the dorsal root ganglion (DRGs) and how this may translate into human sensations. Results: In large A-fiber related DRGs ATX-II (5 nM) enhances persistent and resurgent sodium currents, but failed to do so in small C-fiber linked DRGs when investigated using the whole-cell patch-clamp technique. Resurgent currents are thought to depend on the presence of the sodium channel β4-subunit. Using RT-qPCR experiments, we show that small DRGs express significantly less β4 mRNA than large sensory neurons. With the β4-C-terminus peptide in the pipette solution, it was possible to evoke resurgent currents in small DRGs and in Nav1.7 or Nav1.6 expressing HEK293/N1E115 cells, which were enhanced by the presence of extracellular ATX-II. When injected into the skin of healthy volunteers, ATX-II induces painful and itch-like sensations which were abolished by mechanical nerve block. Increase in superficial blood flow of the skin, measured by Laser doppler imaging is limited to the injection site, so no axon reflex erythema as a correlate for C-fiber activation was detected. Conclusion: ATX-II enhances persistent and resurgent sodium currents in large diameter DRGs, whereas small DRGs depend on the addition of β4-peptide to the pipette recording solution for ATX-II to affect resurgent currents. Mechanical A-fiber blockade abolishes all ATX-II effects in human skin (e.g. painful and itch-like paraesthesias), suggesting that it mediates its effects mainly via activation of A-fibers.

15 March 2013 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CSCarolyn C. Sachse
Carolyn C. Sachse
YKYoung Hye Kim
Young Hye Kim
MAMarianne Agsten
Marianne Agsten
THTobias Huth
Tobias Huth
CAChristian Alzheimer
Christian Alzheimer
DKDoo Yeon Kim
Doo Yeon Kim
BACE1 and presenilin (PS)/γ‐secretase play a major role in Alzheimer's disease pathogenesis by regulating amyloid‐β peptide generation. We recently showed that these secretases also regulate the processing of voltage‐gated sodium channel auxiliary β‐subunits and thereby modulate membrane excitability. Here, we report that KCNE1 and KCNE2, auxiliary subunits of voltage‐gated potassium channels, undergo sequential cleavage mediated by either α‐secretase and PS/γ‐secretase or BACE1 and PS/γ‐secretase in cells. Elevated α‐secretase or BACE1 activities increased C‐terminal fragment (CTF) levels of KCNE1 and 2 in human embryonic kidney (HEK293T) and rat neuroblastoma (B104) cells. KCNE‐CTFs were then further processed by PS/γ‐secretase to KCNE intracellular domains. These KCNE cleavages were specifically blocked by chemical inhibitors of the secretases in the same cell models. We also verified our results in mouse cardiomyocytes and cultured primary neurons. Endogenous KCNE1‐ and KCNE2‐CTF levels increased by 2‐to 4‐fold on PS/γ‐secretase inhibition or BACE1 overexpression in these cells. Furthermore, the elevated BACE1 activity increased KCNE1 processing and shifted KCNE1/KCNQ1 channel activation curve to more positive potentials in HEK cells. KCNE1/KCNQ1 channel is a cardiac potassium channel complex, and the positive shift would lead to a decrease in membrane repolarization during cardiac action potential. Together, these results clearly showed that KCNE1 and KCNE2 cleavages are regulated by BACE1 and PS/γ‐secretase activities under physiological conditions. Our results also suggest a functional role of KCNE cleavage in regulating voltage‐gated potassium channels.—Sachse, C. C., Kim, Y. H., Agsten, M., Huth, T., Alzheimer, C., Kovacs, D. M., and Kim, D. Y. BACE1 and presenilin/γ‐secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage‐gated potassium channels. FASEB J. 27, 2458–2467 (2013). www.fasebj.org